Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project
HealthyW8
Empowering Healthy Lifestyle Behaviour Through Personalized Intervention Portfolios to Prevent and Control Obesity During Vulnerable Stages of Life: The HealthyW8 Project.
2 other identifiers
interventional
2,720
8 countries
13
Brief Summary
The goal of the HealthyW8 study (an intervention study) is: To assess the usefulness and effects of a digital-based healthy lifestyle recommender system (HRLS) on the prevention of obesity in the following propulations: schoolchildren (5-10 y) and their parents, young adults (18-25 y) and elders (\>65 y). The main questions it aims to answer are: Outcome 1: To select and validate a tool-assisted 3-mo intervention (mostly digital) by iteratively testing the HLRS on reducing risk of overweight/obesity among the described age groups. Outcome 2: To assess the effect of 1-y interventions (mostly digital) with the HLRS described and further iteratively improved previously (outcome 1) on reducing risk of overweight/obesity at described ages. Researchers will compare the intervention group before the intervention (baseline) and after it (3-mo intervention trial), or control group (standard care) vs. Intervention group (1-y intervention) to see changes on changes in overweight/obesity, and related parameters (body composition and biomarkers). Participants will follow the HLRS recommendations (meal plans, physical activity and sleep pattern measures and recommendations, assessment of behavioural/psychological aspects, and motivational features through digital devices), which will be assessed by means of measurement of body weight, body composition, and biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Typical duration for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
ExpectedJuly 1, 2025
April 1, 2025
14 days
April 7, 2025
June 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in BMI
The Primary Outcome (to be measured every 3 months) will be the change of BMI (kg/m\^2) measuring body weight in kilograms and height in meters\^2 as combined to obtain BMI data (kg/m\^2) after the 12-month intervention of healthy lifestyle recommender solutions (HLRS) in the selected age groups (5-12 y.o. children and families; 18-25 y.o. young adults; and \>65 y.o. elderly people).
Baseline and every 3 months up to 12 months
Secondary Outcomes (2)
Change of visceral body fat
Baseline and every 3 months up to 12 months
Body composition and biomarkers
Baseline and every 6 months up to 12 months
Study Arms (3)
School-children (including families)
EXPERIMENTALHLRS intervention on 5-12 year-old school-children (including families) adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages).
Young adults
EXPERIMENTALHLRS intervention on 18-25-year-old young adults adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages).
Elderly people
EXPERIMENTALHLRS intervention on \>65-year-old elderly people adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages).
Interventions
Healthy Lifestyle Recommender Solution (HLRS) will be developed as intervention tool for the trials. It integrates tools (mostly digital): a meal recommender to propose balanced and individually adapted meal plans, physical activity and sleep pattern measures and recommendations, assessment of behavioural/psychological aspects, and motivational features for sustained engagement and adherence. Within our multi-disciplinary portfolio approach, a set of predominantly eHealth solutions applied during the intervention trials for overweight/obesity prevention, developed in a participatory design approach with relevant stakeholders. This will include the HLRS, thus combining motivational features (nudging, gamification), targeted psychological support, dietary and physical activity advice, though also additional recommendations (healthy eating guidelines...) or education materials will be provided. Intervention trials/studies.
Eligibility Criteria
You may qualify if:
- Overweight (BMI between 25-30 kg/m\^2)
- To have a smart phone
You may not qualify if:
- Individuals with manifest chronic diseases
- Individuals with cognitive diseases
- Individuas not able to lead an independent life
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundació d'investigació Sanitària de les Illes Balearslead
- Luxembourg Institute of Healthcollaborator
- University of Évoracollaborator
- University of Coimbracollaborator
- Eindhoven University of Technologycollaborator
- Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbHcollaborator
- Deutsches Forschungszentrum für Künstliche Intelligenz (DFKI)collaborator
- Technical University of Denmarkcollaborator
Study Sites (13)
Virtech Ood
Sofia, 1784, Bulgaria
Regional Cluster North-East
Varna, 9002, Bulgaria
Danmarks Tekniske Universitet
Kongens Lyngby, 2800, Denmark
Leibniz-Institut Fur Praventionsforschung Und Epidemiologie - Bips Gmbh
Bremen, 28359, Germany
Deutsches Forschungszentrum Fur Kunstliche Intelligenz Gmbh
Kaiserslautern, 67663, Germany
Universita Degli Studi Di Scienze Gastronomiche
Bra, 12042, Italy
Luxembourg Institute of Health
Luxembourg, 1526, Luxembourg
Technische Universiteit Eindhoven
Eindhoven, 5612 AE, Netherlands
Universidade de Coimbra
Coimbra, 3004-531, Portugal
Universidade de Evora
Evora, 7000 803, Portugal
Fundacio Institut D'Investigacio Sanitaria Illes Balears (Idisba)
Palma de Mallorca, Balearic Islands, 07122, Spain
Centre de Recerca En Economia I Desenvolupament Agroalimentari-Upc-Irta
Castelldefels, 08860, Spain
Centro de Investigacion Y Tecnologia Agroalimentaria de Aragon
Zaragoza, 50059, Spain
Related Publications (1)
Vahid F, Dessenne C, Tur JA, Bouzas C, Devaux Y, Malisoux L, Monserrat-Mesquida M, Sureda A, Desai MS, Turner JD, Lamy E, Perez-Jimenez M, Ravn-Haren G, Andersen R, Forberger S, Nagrani R, Ouzzahra Y, Fontefrancesco MF, Onorati MG, Bonetti GG, de-Magistris T, Bohn T. Multicomponent (bio)markers for obesity risk prediction: a scoping review protocol. BMJ Open. 2024 Mar 8;14(3):e083558. doi: 10.1136/bmjopen-2023-083558.
PMID: 38458803BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Torsten Bohn, PhD
Luxembourg Institute of Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2025
First Posted
June 8, 2025
Study Start
July 1, 2025
Primary Completion
July 15, 2025
Study Completion (Estimated)
June 30, 2028
Last Updated
July 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
There are restrictions on the availability of data for this trial, due to the signed consent agreements around data sharing, which only allow access to external re-searchers for studies following the project purposes. Researchers wishing to access the trial data used in this study can make a request to pep.tur@uib.es